Real‐World Outcomes of FFRangio‐Guided Treatment for Coronary Artery Disease in Acute Versus Chronic Coronary Syndromes
Journal of the American Heart Association · 2026
DOI: 10.1161/jaha.125.044105 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Guy Witberg und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Rabin Medical Centre Petach-Tikva Israel. Hauptthemen laut MEDLINE: Fractional Flow Reserve, Myocardial, Coronary Angiography, Coronary Artery Disease, Acute Coronary Syndrome. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The use of angiogram‐based fractional flow reserve technologies in routine clinical practice is increasing steadily. Available data suggest that it is associated with comparable clinical outcomes compared with wire‐based fractional flow reserve (FFR), but evidence is still limited, especially in patients with acute coronary syndromes (ACSs). The aim of this study was to examine the real‐world clinical outcomes of an angiogram based fractional flow reserve technology (FFRangio; CathWorks, Kfar‐Saba, Israel) to guide treatment for coronary artery disease in patients presenting with acute versus chronic coronary syndromes (CCSs).
Methods
This is a retrospective, observational study. Our cohort included consecutive patients undergoing coronary angiography in 7 centers (Japan, 6; Israel, 1), whose treatment was guided by FFRangio between January 2021 and December 2023. The primary end point was 2‐year cumulative incidence of major adverse cardiac events, stratified by presentation (ACS/CCS) and treatment strategy (revascularization/deferral).
Results
Overall, 2245 patients (ACS, 756; CCS, 1489) were included. Patients with ACS were younger and more likely to be diabetic. At 2 years, ACS presentation resulted in higher risk of major adverse cardiac events (9.8% versus 5.6%; HR, 1.80; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology Rabin Medical Centre Petach-Tikva Israel.
- Tel-Aviv University Tel-Aviv Israel.
- Fukuyama Cardiovascular Hospital Fukuyama Japan.
- Ichinomiya Nishi Hospital Ichinomiya Aichi Japan.
- Fukuoka Sanno Hospital Fukuoka Japan.
- Saga-Ken Medical Centre Saga Japan.
ORCID-Profile: Guy Witberg, Yuetsu Kikuta, Kazuhiro Dan, Hiroyoshi Yokoi, Yutaka Hikichi, Mamoru Nanasato, Yeela Talmor-Barkan, Amos Levi, Ran Kornowski, Hitoshi Matsuo
Zitieren
APA
Witberg, G., Kikuta, Y., Dan, K., Yokoi, H., Hikichi, Y., Nanasato, M., Tanigaki, T., Talmor-Barkan, Y., Levi, A., Kornowski, R., & Matsuo, H. (2026). Real‐World Outcomes of FFRangio‐Guided Treatment for Coronary Artery Disease in Acute Versus Chronic Coronary Syndromes. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.044105
Vancouver
Witberg G, Kikuta Y, Dan K, Yokoi H, Hikichi Y, Nanasato M, et al. Real‐World Outcomes of FFRangio‐Guided Treatment for Coronary Artery Disease in Acute Versus Chronic Coronary Syndromes. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.044105
BibTeX
@article{Witberg2026,
author = {Witberg, Guy and Kikuta, Yuetsu and Dan, Kazuhiro and Yokoi, Hiroyoshi and Hikichi, Yutaka and Nanasato, Mamoru and Tanigaki, Toru and Talmor-Barkan, Yeela and Levi, Amos and Kornowski, Ran and Matsuo, Hitoshi},
title = {Real‐World Outcomes of FFRangio‐Guided Treatment for Coronary Artery Disease in Acute Versus Chronic Coronary Syndromes},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.125.044105}
}
EUVIMED